Pfizer shareholders to vote on proposal from SRI investors for review of lobbying activities

The proposal would have the firm review its support of the controversial lobby group, ALEC.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this